OBJECTIVES: Dental implant abutments are fundamental prosthetic components within dentistry that require optimal biocompatibility. The primary aim of this cross-sectional study was to preliminarily assess differences in the pro-inflammatory cytokine and bone metabolism mediator protein expression in the peri-implant crevicular fluid (PICF) adjacent to transmucosal abutments. MATERIAL AND METHODS: Abutments were fabricated from either titanium or zirconia in patients previously receiving single-tooth implant therapy. All subjects sampled in this study had an identical implant system and implant-abutment connection. Participants (n = 46) had an average time of clinical function for 22 months (6.2-72.8 months, ±SD 17 months) and received a clinical and radiographic examination of the implant site at the time of PICF sampling using a paper strip-based sampling technique. Cytokine, chemokine, and bone metabolism mediator quantities (picograms/30 s) were determined using a commercial 22-multiplexed fluorescent bead-based immunoassay instrument. A total of 19 pro-inflammatory cytokines and seven bone metabolism mediators were evaluated. RESULTS: Multivariable analyses provided no evidence of a group (titanium or zirconia), gender, or age effect with regard to the expression of pro-inflammatory mediators evaluated. Significant (P = 0.022) differences were observed for the bone mediator leptin, with titanium abutments demonstrating significantly elevated levels in comparison with zirconia. Osteopontin demonstrated a significant (P = 0.0044) correlation with age of the subjects. CONCLUSIONS: No significant differences in pro-inflammatory cytokine or bone metabolism mediator profiles were observed biochemically, with the exception of leptin, for the abutment biomaterials of titanium or zirconia The molecular PICF findings support the observed clinical biocompatibility of both titanium and zirconia abutments.
RCT Entities:
OBJECTIVES: Dental implant abutments are fundamental prosthetic components within dentistry that require optimal biocompatibility. The primary aim of this cross-sectional study was to preliminarily assess differences in the pro-inflammatory cytokine and bone metabolism mediator protein expression in the peri-implant crevicular fluid (PICF) adjacent to transmucosal abutments. MATERIAL AND METHODS: Abutments were fabricated from either titanium or zirconia in patients previously receiving single-tooth implant therapy. All subjects sampled in this study had an identical implant system and implant-abutment connection. Participants (n = 46) had an average time of clinical function for 22 months (6.2-72.8 months, ±SD 17 months) and received a clinical and radiographic examination of the implant site at the time of PICF sampling using a paper strip-based sampling technique. Cytokine, chemokine, and bone metabolism mediator quantities (picograms/30 s) were determined using a commercial 22-multiplexed fluorescent bead-based immunoassay instrument. A total of 19 pro-inflammatory cytokines and seven bone metabolism mediators were evaluated. RESULTS: Multivariable analyses provided no evidence of a group (titanium or zirconia), gender, or age effect with regard to the expression of pro-inflammatory mediators evaluated. Significant (P = 0.022) differences were observed for the bone mediator leptin, with titanium abutments demonstrating significantly elevated levels in comparison with zirconia. Osteopontin demonstrated a significant (P = 0.0044) correlation with age of the subjects. CONCLUSIONS: No significant differences in pro-inflammatory cytokine or bone metabolism mediator profiles were observed biochemically, with the exception of leptin, for the abutment biomaterials of titanium or zirconia The molecular PICF findings support the observed clinical biocompatibility of both titanium and zirconia abutments.
Authors: Jennifer T Steigenga; Khalaf F al-Shammari; Francisco H Nociti; Carl E Misch; Hom-Lay Wang Journal: Implant Dent Date: 2003 Impact factor: 2.454
Authors: S A Shapses; M Cifuentes; L Spevak; H Chowdhury; J Brittingham; A L Boskey; D T Denhardt Journal: Calcif Tissue Int Date: 2003-07 Impact factor: 4.333
Authors: A M Pabst; C Walter; A Bell; M Weyhrauch; I Schmidtmann; H Scheller; K M Lehmann Journal: Clin Oral Investig Date: 2015-09-23 Impact factor: 3.573
Authors: Katharina Kuhn; Heike Rudolph; Michael Graf; Matthias Moldan; Shaoxia Zhou; Martin Udart; Andrea Böhmler; Ralph G Luthardt Journal: Trials Date: 2015-10-15 Impact factor: 2.279
Authors: Maria Kassapidou; Victoria Franke Stenport; Carina B Johansson; Anna-Karin Östberg; Petra Hammarström Johansson; Lars Hjalmarsson Journal: J Oral Maxillofac Res Date: 2021-12-31
Authors: Vygandas Rutkunas; Rokas Borusevicius; Evaldas Balciunas; Urte Jasinskyte; Milda Alksne; Egidijus Simoliunas; Stefan Zlatev; Vasilena Ivanova; Virginija Bukelskiene; Eitan Mijiritsky Journal: Int J Environ Res Public Health Date: 2022-09-05 Impact factor: 4.614